The majority of children and teens with chronic skin diseases such as acne, eczema, psoriasis, alopecia areata (hair loss) and vitiligo (pigment loss) feel stigmatized by peers for their condition and are sometimes bullied, ...
8 hours ago
0
0
Hair loss (alopecia) may not be as common in kids as adults, but there are variety of a reasons it may happen. While it can be upsetting for both parents and children, the condition usually improves once the cause is identified ...
Mar 25, 2024
0
0
The annual meeting of the American Academy of Dermatology was held from March 8 to 12 in San Diego and attracted participants from around the world, including clinicians, academicians, allied health professionals, and others ...
Mar 20, 2024
0
0
A new paper in Rheumatology finds that rheumatic diseases can lead to reproductive problems, though some conditions have more detrimental effects than others.
Mar 20, 2024
0
0
In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report.
Oct 10, 2023
0
58
For patients with alopecia areata (AA), corticosteroids are the most commonly used treatment, and by one year, 71.8 percent are receiving no treatment, according to a study published online Sept. 20 in JAMA Dermatology.
Sep 20, 2023
0
1
A new type of medication, JAK inhibitors, can effectively treat moderate to severe alopecia areata, a hair loss condition that has been historically hard to treat.
Aug 17, 2023
0
9
Janus kinase (JAK) inhibitors are associated with more hair regrowth than placebo for patients with alopecia areata, according to a review published online June 27 in JAMA Network Open.
Jul 19, 2023
0
17
The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.
Jun 27, 2023
0
1
Just a year after the U.S. Food and Drug Administration (FDA) approved the first treatment for severe alopecia areata, the federal agency has approved a second treatment for the disfiguring skin disease—both the result ...
Jun 27, 2023
0
15
